Crossmark

The FDA-approved natural product dihydroergocristine reduces the production of the Alzheimer’s disease amyloid-β peptides

Published Online: 2015-11-16

Authors

Lei, Xiling

Yu, Jing

Niu, Qi

Liu, Jianhua

Fraering, Patrick C.

Wu, Fang
License Information

Text and Data Mining valid from 2015-11-16

Version of Record valid from 2015-11-16
More Information

Article History

Received: 31 March 2015

Accepted: 15 October 2015

First Online: 16 November 2015

Competing interests

: The authors declare no competing financial interests.

Document is current